Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients

UnknownOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 6, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Onco4D Biodynamic Chemotherapy Selection Assay

The Onco4D Biodynamic Chemotherapy Selection Assay uses Motility Contrast Tomography (MCT) to measure ex-vivo fresh tumor biopsy response when challenged by an array of chemotherapeutic agents. A machine learning algorithm uses the MCT datastream to predict in vivo tumor response or non response to chemotherapy.

Trial Locations (1)

46241

RECRUITING

Animated Dynamics, Inc., Indianapolis

Sponsors
All Listed Sponsors
lead

Animated Dynamics, Inc.

INDUSTRY

NCT03164863 - Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients | Biotech Hunter | Biotech Hunter